Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 898 | 962 | 3,388 | 805 | 792 |
| Gross Profit | 898 | 962 | 3,388 | 805 | 790 |
| Operating Expenses | 39,882 | 22,127 | 22,588 | 18,644 | 13,170 |
| Operating Income | -38,984 | -21,165 | -19,200 | -17,839 | -12,378 |
| Interest Expense | 357 | -142 | -153 | -124 | -20 |
| Other Income | -35 | 3 | 5 | -30 | -282 |
| Pre-tax Income | -39,376 | -21,020 | -19,042 | -17,745 | -12,640 |
| Net Income Continuous | -39,376 | -21,020 | -19,042 | -17,745 | -12,633 |
| Net Income | $-39,376 | $-21,020 | $-19,042 | $-17,745 | $-12,633 |
| EPS Basic Total Ops | -1.09 | -0.59 | -0.54 | -0.80 | -4.05 |
| EPS Basic Continuous Ops | -1.09 | -0.59 | -0.54 | -0.80 | -4.02 |
| EPS Diluted Total Ops | -1.09 | -0.59 | -0.54 | -0.80 | -4.05 |
| EPS Diluted Continuous Ops | -1.09 | -0.59 | -0.54 | -0.80 | -4.02 |
| EBITDA(a) | $-38,496 | $-20,884 | $-18,954 | $-17,652 | $-12,231 |